|1.||Giardiello, Francis M: 5 articles (02/2015 - 01/2009)|
|2.||Eng, Charis: 4 articles (10/2015 - 11/2003)|
|3.||Heald, Brandie: 3 articles (10/2015 - 08/2012)|
|4.||Burke, Carol A: 3 articles (08/2015 - 08/2010)|
|5.||Offerhaus, G Johan A: 3 articles (11/2011 - 01/2009)|
|6.||Lim, Kiat Hon: 2 articles (10/2015 - 12/2009)|
|7.||LaGuardia, Lisa: 2 articles (08/2015 - 08/2012)|
|8.||O'Malley, Margaret: 2 articles (08/2015 - 08/2012)|
|9.||Church, James M: 2 articles (02/2015 - 01/2005)|
|10.||Plawski, Andrzej: 2 articles (06/2014 - 01/2013)|
01/01/2004 - "Histological, histochemical and immunohistochemical studies of 50 solitary juvenile polyps (JP) and 50 JP from children with juvenile polyposis syndrome (JPS) were performed. "
03/01/2002 - "The aim of this study was to review our experience with juvenile polyposis syndrome with emphasis on the diversity of polyp pathology and distribution and the recommended treatment. "
12/01/2015 - "Juvenile polyposis syndrome (JPS) is a rare autosomal dominant disorder characterized by the development of multiple hamartomatous polyps in the gastrointestinal tract. "
09/07/2015 - "Juvenile polyposis syndrome (JPS) is an infrequent autosomal dominant hereditary predisposition to the occurrence of hamartomatous polyps in the colon and rectum. "
01/01/2015 - "Juvenile polyposis syndrome (JPS) is a rare genetic disorder characterized by juvenile polyps of the gastrointestinal tract. "
01/01/2015 - "This study evaluated the differential impact of SMAD4 and BMPR1A gene mutations on cancer risk and oncological phenotype in patients with juvenile polyposis syndrome. "
01/01/2015 - "Genotype-defined cancer risk in juvenile polyposis syndrome."
06/10/2013 - "Loss of BMP signaling pathway members in the midgut epithelium or loss of the BMP signaling ligand decapentaplegic from visceral muscle resulted in phenotypes similar to those described for juvenile polyposis syndrome, a human intestinal tumor caused by mutations in BMP signaling pathway components. "
10/01/2012 - "Six patients (14%) developed cancer; 4 had cancer at the time of diagnosis of juvenile polyposis syndrome, 3 developed cancer while on surveillance (1 patient had a second primary). "
09/01/2009 - "Juvenile polyposis syndrome (JPS) is a hereditary syndrome associated with several germline mutations, and carries a significant risk for future cancer development. "
|3.||Colorectal Neoplasms (Colorectal Cancer)
06/01/2010 - "The conditions Juvenile Polyposis Syndrome (JPS) and Hereditary Mixed Polyposis Syndrome (HMPS) are associated with an increased risk of colorectal carcinoma. "
04/01/2007 - "The challenge for adult and pediatric gastroenterologists is determining the precise risk of colorectal cancer in patients with juvenile polyposis syndrome. "
01/01/2002 - "Fatal colorectal cancer in juvenile polyposis syndrome."
11/28/2011 - "In addition, juvenile polyposis syndrome provides a unique model to study colorectal cancer pathogenesis in general and gives insight in the molecular genetic basis of cancer. "
01/01/2013 - "Juvenile polyps are relatively common findings in children, while juvenile polyposis syndrome (JPS) is a rare hereditary syndrome entailing an increased risk of colorectal cancer. "
07/01/2004 - "Following histopathological study, the diagnosis of Juvenile polyposis syndrome was made, a very rare entity and is known to lead to adenocarcinoma of the gastrointestinal tract. "
09/07/2015 - "Juvenile polyposis syndrome patients are at increased risk of colorectal adenocarcinoma. "
12/01/2014 - "Patients with juvenile polyposis syndrome (JPS), a hereditary autosomal dominant hamartomatous polyposis syndrome, are at increased risk for colorectal adenocarcinoma. "
07/01/2011 - "Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue."
01/01/2005 - "The aim of this study was to evaluate the long-term outcomes of the surgical options in juvenile polyposis syndrome patients who present with symptomatic colonic polyps. "
04/01/2007 - "Colonic polyps, including isolated juvenile polyps, juvenile polyposis syndrome, FAP, AFAP and MYH-associated polyposis, are discussed in the present review."
|1.||Attenuated familial adenomatous polyposis
|2.||Juvenile polyposis syndrome
|3.||Cyclooxygenase 2 (Cyclooxygenase-2)
|4.||Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
|5.||Transforming Growth Factor beta (TGF-beta)
|6.||Immunoglobulin G (IgG)